Learn More
Medchemexpress LLC Dihydroergotamine mesylate | 6190-39-2 | 99.9% | 5 MG

Supplier: Medchemexpress LLC HYB0670A5MG
Dihydroergotamine mesylate is a blood-brain barrier (BBB)-permeable ergot alkaloid used in migraine research. It targets 5-HT Receptors within GPCR/G Protein and neuronal signaling pathways.
- Acts as a 5-HT receptor agonist.
- Reduces cell survival in A549 and NCI-H226 cells.
- Inhibits cell survival in Hep3B, PLC/PRF/5, Huh7, and HepG2 cells.
- Induces mitochondrial morphologic alterations and dysfunction.
- Increases reactive oxygen species (ROS) generation.
- Triggers apoptosis and disrupts ATP production.
- Inhibits STAT3 activation and enhances Mcl-1 protein stability.
- Inhibits tumor growth in HepG2 xenografted mice.
- Reduces Ki67 positive cells, Mcl-1, p-Mcl-1, and p-ERK expression.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.